[RDHL] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -350.77%
YoY- -200.62%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,796 3,599 12,798 17,552 18,346 18,236 22,071 -81.30%
PBT 761 50,241 -3,729 -35,701 -11,711 -17,137 -24,373 -
Tax 0 421 -6,219 28,593 2,552 10 -81 -
NP 761 50,241 2,490 -64,294 -14,263 -17,137 -24,373 -
Tax Rate 0.00% -0.84% - - - - - -
Total Cost 1,035 -46,642 10,308 81,846 32,609 35,373 46,444 -92.13%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 42.37 1,395.97 19.46 -366.31 -77.74 -93.97 -110.43 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 4.83 20.44 1.07 -40.29 -10.04 -13.36 -19.65 -
EPS Diluted 4.83 20.44 1.07 -40.29 -10.04 -13.36 -19.65 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.